Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of Prostate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03327675
What this trial is testing

High Precision Imaging of Prostate Specific Membrane Antigen for Personalized Treatment in Prostate Cancer

Who this might be right for
Prostate Cancer
Universitaire Ziekenhuizen KU Leuven 188
Large-scale testing (Phase 3)Active Not RecruitingNCT04720157
What this trial is testing

An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)

Who this might be right for
Prostatic Neoplasms
Novartis Pharmaceuticals 1,140
Large-scale testing (Phase 3)Study completedNCT01308567
What this trial is testing

Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Sanofi 1,168
Testing effectiveness (Phase 2)Study completedNCT02854436
What this trial is testing

An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 289
Testing effectiveness (Phase 2)Study completedNCT02217709
What this trial is testing

Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+3 more
University of Southern California 26
Large-scale testing (Phase 3)Active Not RecruitingNCT02799706
What this trial is testing

Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 885
Not applicableStudy completedNCT00214162
What this trial is testing

CHESS Caregivers Study: Web-based Support for Informal Caregivers in Cancer

Who this might be right for
Breast CancerProstate Cancer
University of Wisconsin, Madison 235
Large-scale testing (Phase 3)Looking for participantsNCT03495427
What this trial is testing

PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores

Who this might be right for
Prostate CancerRecurrent Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute 60
Testing effectiveness (Phase 2)UnknownNCT04903873
What this trial is testing

Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors

Who this might be right for
Solid TumorRenal Cell Cancer MetastaticNon-Small Cell Lung Cancer+2 more
Eutilex 110
Not applicableNot Yet RecruitingNCT06634173
What this trial is testing

The Diagnostic Value of FAPI PET/CT in Staging of Newly Diagnosed Prostate Cancer

Who this might be right for
Prostate CancerProstate Cancer Metastatic
The Netherlands Cancer Institute 30
Testing effectiveness (Phase 2)Looking for participantsNCT04812366
What this trial is testing

Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
University of British Columbia 315
Testing effectiveness (Phase 2)Looking for participantsNCT07689656
What this trial is testing

A Clinical Study of [68Ga]Ga-ELI421 Injection PET Imaging in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 50
Not applicableStudy completedNCT01241656
What this trial is testing

Decision Support Interventions (DESI) for Prostate Cancer Screening - Study 1

Who this might be right for
Healthy Men Age 50 Who Are Considering PSA Screening
University of North Carolina, Chapel Hill 2,521
Early research (Phase 1)Looking for participantsNCT06492122
What this trial is testing

Study With [225Ac]Ac-FL-020 in mCRPC Participants

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Full-Life Technologies UK Limited 50
Not applicableStudy completedNCT07086651
What this trial is testing

Learn About Two Medicines (Apalutamide and Enzalutamide) in People With Metastatic Castration-sensitive Prostate Cancer (mCSPC)

Who this might be right for
Metastatic Castration Sensitive Prostate Cancer (mCSPC)Cancer of the ProstateProstate Neoplasms+1 more
Pfizer 1,300
Early research (Phase 1)Study completedNCT03497377
What this trial is testing

Evaluation of 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer.

Who this might be right for
Metastatic Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 25
Large-scale testing (Phase 3)Study completedNCT00002511
What this trial is testing

Radiation Therapy Compared With No Further Treatment Following Surgery in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 1,005
Early research (Phase 1)Study completedNCT04216134
What this trial is testing

68Ga-PSMA-11 PET for the Diagnosis of Biochemically Recurrent Prostate Cancer

Who this might be right for
Biochemically Recurrent Prostate Carcinoma
City of Hope Medical Center 19
Very early researchActive Not RecruitingNCT05683964
What this trial is testing

Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expression

Who this might be right for
Prostate AdenocarcinomaProstate CancerMetastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Beth Israel Deaconess Medical Center 9
Testing effectiveness (Phase 2)Study completedNCT00108732
What this trial is testing

A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer

Who this might be right for
Recurrent Prostate CarcinomaStage I Prostate CancerStage IIA Prostate Cancer+2 more
National Cancer Institute (NCI) 50
Next Page